LOX and fibrosis: In contrast, administration of Lox inhibitor, β-aminopropionitrile, suppressed the accumulation of cross-linked collagens and the stiffness of collagen fibril in the ECM, accelerating fibrosis reversal after CCl4 withdrawal [22,23].